JP2011074022A - 幹細胞増殖因子(SCF)mRNA発現促進剤 - Google Patents
幹細胞増殖因子(SCF)mRNA発現促進剤 Download PDFInfo
- Publication number
- JP2011074022A JP2011074022A JP2009227631A JP2009227631A JP2011074022A JP 2011074022 A JP2011074022 A JP 2011074022A JP 2009227631 A JP2009227631 A JP 2009227631A JP 2009227631 A JP2009227631 A JP 2009227631A JP 2011074022 A JP2011074022 A JP 2011074022A
- Authority
- JP
- Japan
- Prior art keywords
- scf
- mrna expression
- extract
- stem cell
- parts
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108020004999 messenger RNA Proteins 0.000 title claims abstract description 35
- 210000000130 stem cell Anatomy 0.000 title abstract description 6
- 239000000284 extract Substances 0.000 claims abstract description 38
- 241000196324 Embryophyta Species 0.000 claims abstract description 18
- 239000004480 active ingredient Substances 0.000 claims abstract description 9
- 241000219422 Urtica Species 0.000 claims description 20
- 235000009108 Urtica dioica Nutrition 0.000 claims description 18
- 102100032528 C-type lectin domain family 11 member A Human genes 0.000 claims description 8
- 101710167766 C-type lectin domain family 11 member A Proteins 0.000 claims description 8
- 241001105098 Angelica keiskei Species 0.000 abstract description 3
- 241000218203 Coptis japonica Species 0.000 abstract description 3
- 239000000126 substance Substances 0.000 abstract description 3
- 230000000694 effects Effects 0.000 abstract description 2
- 241000674251 Urtica laetevirens Species 0.000 abstract 1
- 238000000605 extraction Methods 0.000 description 23
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 18
- 230000001737 promoting effect Effects 0.000 description 14
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 12
- 210000003491 skin Anatomy 0.000 description 12
- 210000004694 pigment cell Anatomy 0.000 description 9
- 239000002994 raw material Substances 0.000 description 9
- 239000002904 solvent Substances 0.000 description 9
- 238000011282 treatment Methods 0.000 description 9
- 210000004027 cell Anatomy 0.000 description 8
- 239000000203 mixture Substances 0.000 description 6
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 230000035755 proliferation Effects 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 238000012937 correction Methods 0.000 description 4
- 235000013399 edible fruits Nutrition 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 239000012264 purified product Substances 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- -1 aliphatic alcohols Chemical class 0.000 description 3
- 239000000470 constituent Substances 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 239000012528 membrane Substances 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 239000011259 mixed solution Substances 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 239000002798 polar solvent Substances 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 150000005846 sugar alcohols Polymers 0.000 description 3
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- 102100031181 Glyceraldehyde-3-phosphate dehydrogenase Human genes 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 241000282412 Homo Species 0.000 description 2
- WTDRDQBEARUVNC-LURJTMIESA-N L-DOPA Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-LURJTMIESA-N 0.000 description 2
- 102000016971 Proto-Oncogene Proteins c-kit Human genes 0.000 description 2
- 108010014608 Proto-Oncogene Proteins c-kit Proteins 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 239000002537 cosmetic Substances 0.000 description 2
- 238000005238 degreasing Methods 0.000 description 2
- 210000005175 epidermal keratinocyte Anatomy 0.000 description 2
- 210000002950 fibroblast Anatomy 0.000 description 2
- 108020004445 glyceraldehyde-3-phosphate dehydrogenase Proteins 0.000 description 2
- 210000002510 keratinocyte Anatomy 0.000 description 2
- 230000008099 melanin synthesis Effects 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 238000003757 reverse transcription PCR Methods 0.000 description 2
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 1
- 201000004384 Alopecia Diseases 0.000 description 1
- 235000009604 Chrysanthemum X morifolium Nutrition 0.000 description 1
- 244000189548 Chrysanthemum x morifolium Species 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- AHMIDUVKSGCHAU-UHFFFAOYSA-N Dopaquinone Natural products OC(=O)C(N)CC1=CC(=O)C(=O)C=C1 AHMIDUVKSGCHAU-UHFFFAOYSA-N 0.000 description 1
- 240000008620 Fagopyrum esculentum Species 0.000 description 1
- 235000009419 Fagopyrum esculentum Nutrition 0.000 description 1
- 102100020880 Kit ligand Human genes 0.000 description 1
- AHMIDUVKSGCHAU-LURJTMIESA-N L-dopaquinone Chemical compound [O-]C(=O)[C@@H]([NH3+])CC1=CC(=O)C(=O)C=C1 AHMIDUVKSGCHAU-LURJTMIESA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- 102100027754 Mast/stem cell growth factor receptor Kit Human genes 0.000 description 1
- 210000002361 Megakaryocyte Progenitor Cell Anatomy 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 241000209504 Poaceae Species 0.000 description 1
- 208000000453 Skin Neoplasms Diseases 0.000 description 1
- 108010039445 Stem Cell Factor Proteins 0.000 description 1
- 241001486992 Taiwanofungus camphoratus Species 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 102000003425 Tyrosinase Human genes 0.000 description 1
- 108060008724 Tyrosinase Proteins 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 125000000539 amino acid group Chemical group 0.000 description 1
- 239000012752 auxiliary agent Substances 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 210000004271 bone marrow stromal cell Anatomy 0.000 description 1
- 230000003139 buffering effect Effects 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- RXKJFZQQPQGTFL-UHFFFAOYSA-N dihydroxyacetone Chemical compound OCC(=O)CO RXKJFZQQPQGTFL-UHFFFAOYSA-N 0.000 description 1
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000013505 freshwater Substances 0.000 description 1
- 210000004602 germ cell Anatomy 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 210000003714 granulocyte Anatomy 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 230000003676 hair loss Effects 0.000 description 1
- 239000003676 hair preparation Substances 0.000 description 1
- 230000036074 healthy skin Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 210000003958 hematopoietic stem cell Anatomy 0.000 description 1
- 210000003630 histaminocyte Anatomy 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 239000000543 intermediate Substances 0.000 description 1
- 238000007918 intramuscular administration Methods 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 239000003456 ion exchange resin Substances 0.000 description 1
- 229920003303 ion-exchange polymer Polymers 0.000 description 1
- 239000003446 ligand Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 239000012454 non-polar solvent Substances 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 206010033675 panniculitis Diseases 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 239000002953 phosphate buffered saline Substances 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 238000003753 real-time PCR Methods 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- 201000000849 skin cancer Diseases 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 210000004304 subcutaneous tissue Anatomy 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 239000008399 tap water Substances 0.000 description 1
- 235000020679 tap water Nutrition 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 210000003556 vascular endothelial cell Anatomy 0.000 description 1
- 239000002349 well water Substances 0.000 description 1
- 235000020681 well water Nutrition 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
Landscapes
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
【解決手段】幹細胞増殖因子(SCF)mRNA発現促進剤にアシタバ、イラクサ及びオウレンからなる群より選択される1種又は2種以上の植物からの抽出物を含有せしめる。
【選択図】なし
Description
本発明のSCFmRNA発現促進剤は、アシタバ、イラクサ及びオウレンからなる群より選択される1種又は2種以上の植物からの抽出物を有効成分として含有する。
アシタバ抽出物(試料1)、イラクサ抽出物(試料2)及びオウレン抽出物(試料3)について、以下のようにしてSCFmRNA発現促進作用を試験した。
式中、Aは「試料添加時の補正値」を表し、Bは「試料無添加時の補正値」を表す。
結果を表1に示す。
Claims (1)
- アシタバ、イラクサ及びオウレンからなる群より選択される1種又は2種以上の植物からの抽出物を有効成分として含有することを特徴とする幹細胞増殖因子(SCF)mRNA発現促進剤。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2009227631A JP5545938B2 (ja) | 2009-09-30 | 2009-09-30 | 幹細胞増殖因子(SCF)mRNA発現促進剤 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2009227631A JP5545938B2 (ja) | 2009-09-30 | 2009-09-30 | 幹細胞増殖因子(SCF)mRNA発現促進剤 |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2011074022A true JP2011074022A (ja) | 2011-04-14 |
JP5545938B2 JP5545938B2 (ja) | 2014-07-09 |
Family
ID=44018382
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2009227631A Active JP5545938B2 (ja) | 2009-09-30 | 2009-09-30 | 幹細胞増殖因子(SCF)mRNA発現促進剤 |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP5545938B2 (ja) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2017007989A (ja) * | 2015-06-24 | 2017-01-12 | 日本メナード化粧品株式会社 | 造血幹細胞の分化促進剤 |
WO2017138652A1 (ja) * | 2016-02-12 | 2017-08-17 | 花王株式会社 | メラニン分解抑制剤 |
JP2019081719A (ja) * | 2017-10-30 | 2019-05-30 | 日本メナード化粧品株式会社 | 皮膚外用剤又は内用剤 |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0578222A (ja) * | 1991-05-01 | 1993-03-30 | Sansho Seiyaku Co Ltd | 白髪防止剤 |
JPH08133932A (ja) * | 1994-11-07 | 1996-05-28 | Yoshio Sakaguchi | 併用型頭髪発毛育毛剤 |
JP2001048754A (ja) * | 1999-08-03 | 2001-02-20 | Lion Corp | 毛髪用外用剤、白髪改善・予防方法及び白髪を黒髪に改善させる方法 |
JP2001288052A (ja) * | 2000-04-10 | 2001-10-16 | Maruzen Pharmaceut Co Ltd | チロシナーゼ活性促進剤及び白髪改善剤 |
JP2002020243A (ja) * | 2000-07-06 | 2002-01-23 | Lion Corp | 白髪防止・改善剤 |
JP2003171240A (ja) * | 2001-09-28 | 2003-06-17 | Lion Corp | 白髪予防改善剤及び毛髪有効成分のスクリーニング方法 |
-
2009
- 2009-09-30 JP JP2009227631A patent/JP5545938B2/ja active Active
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0578222A (ja) * | 1991-05-01 | 1993-03-30 | Sansho Seiyaku Co Ltd | 白髪防止剤 |
JPH08133932A (ja) * | 1994-11-07 | 1996-05-28 | Yoshio Sakaguchi | 併用型頭髪発毛育毛剤 |
JP2001048754A (ja) * | 1999-08-03 | 2001-02-20 | Lion Corp | 毛髪用外用剤、白髪改善・予防方法及び白髪を黒髪に改善させる方法 |
JP2001288052A (ja) * | 2000-04-10 | 2001-10-16 | Maruzen Pharmaceut Co Ltd | チロシナーゼ活性促進剤及び白髪改善剤 |
JP2002020243A (ja) * | 2000-07-06 | 2002-01-23 | Lion Corp | 白髪防止・改善剤 |
JP2003171240A (ja) * | 2001-09-28 | 2003-06-17 | Lion Corp | 白髪予防改善剤及び毛髪有効成分のスクリーニング方法 |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2017007989A (ja) * | 2015-06-24 | 2017-01-12 | 日本メナード化粧品株式会社 | 造血幹細胞の分化促進剤 |
WO2017138652A1 (ja) * | 2016-02-12 | 2017-08-17 | 花王株式会社 | メラニン分解抑制剤 |
CN108697706A (zh) * | 2016-02-12 | 2018-10-23 | 花王株式会社 | 黑色素分解抑制剂 |
JPWO2017138652A1 (ja) * | 2016-02-12 | 2018-12-13 | 花王株式会社 | メラニン分解抑制剤 |
US10966911B2 (en) | 2016-02-12 | 2021-04-06 | Kao Corporation | Melanin decomposition inhibitor |
JP2019081719A (ja) * | 2017-10-30 | 2019-05-30 | 日本メナード化粧品株式会社 | 皮膚外用剤又は内用剤 |
Also Published As
Publication number | Publication date |
---|---|
JP5545938B2 (ja) | 2014-07-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5137457B2 (ja) | 幹細胞増殖因子発現上昇抑制剤 | |
KR20110054022A (ko) | 미백제 및 항노화제, 그리고 피부 화장료 | |
KR20070106569A (ko) | 두발(頭髮) 화장료 | |
KR101787531B1 (ko) | 생약 복합 추출물을 함유하는 탈모 방지용 조성물 | |
JP2011126850A (ja) | 幹細胞増殖因子(SCF)mRNA発現上昇抑制剤及び塩基性線維芽細胞増殖因子(bFGF)mRNA発現上昇抑制剤 | |
JP5545938B2 (ja) | 幹細胞増殖因子(SCF)mRNA発現促進剤 | |
JP2014185131A (ja) | 育毛剤及び育毛用頭髪化粧料 | |
JP2010215571A (ja) | エンドセリン−1mRNA発現上昇抑制剤、塩基性線維芽細胞増殖因子mRNA発現上昇抑制剤及びプロオピオメラノコルチンmRNA発現上昇抑制剤 | |
JP5566733B2 (ja) | エンドセリン−1mRNA発現、幹細胞増殖因子(SCF)mRNA発現抑制剤、塩基性線維芽細胞増殖因子(bFGF)mRNA発現抑制剤、グルタチオン産生促進剤、及びフィラグリン産生促進剤 | |
JP2009235044A (ja) | エンドセリン−1mRNA発現抑制剤、マトリックスメタロプロテアーゼ−9mRNA発現抑制剤、コラーゲン産生促進剤、プロフィラグリン産生促進剤、フィラグリン産生促進剤及びアクアポリン3mRNA発現促進剤 | |
JP2011001326A (ja) | エンドセリン−1mRNA発現抑制剤 | |
JP2009227619A (ja) | エンドセリン−1mRNA発現上昇抑制剤、幹細胞増殖因子mRNA発現上昇抑制剤、塩基性線維芽細胞増殖因子mRNA発現上昇抑制剤及びプロオピオメラノコルチンmRNA発現上昇抑制剤 | |
JP4020285B2 (ja) | 育毛剤原料及び育毛剤組成物 | |
JP6846106B2 (ja) | Dkk1発現促進剤および美白剤 | |
JP2011001328A (ja) | 塩基性線維芽細胞増殖因子mRNA発現上昇抑制剤 | |
KR20150085991A (ko) | 한방 약재성분의 복합추출물이 함유된 피부미백용 화장료 조성물 | |
JP5896618B2 (ja) | メラニン産生抑制剤 | |
JP2010195726A (ja) | デルマトポンチン産生促進剤 | |
JP2022050090A (ja) | I型コラーゲン産生促進剤 | |
JP2009209050A (ja) | 幹細胞増殖因子mRNA発現上昇抑制剤及び塩基性線維芽細胞増殖因子mRNA発現上昇抑制剤 | |
JPH11147833A (ja) | コラゲナーゼ阻害剤 | |
KR20000024876A (ko) | 콜라겐 합성 촉진제를 포함하는 창상 치유용 피부 조성물 | |
JP2009227620A (ja) | 幹細胞増殖因子mRNA発現上昇抑制剤、塩基性線維芽細胞増殖因子mRNA発現上昇抑制剤及びプロオピオメラノコルチンmRNA発現上昇抑制剤 | |
JP7315940B2 (ja) | 線維芽細胞増殖因子-5発現抑制剤 | |
JP2010215535A (ja) | メラニン産生抑制剤 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20120921 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20121005 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20131030 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20131227 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20140507 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20140512 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 5545938 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |